TRIAMCINOLONE ACETONIDE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: TRIAMCINOLONE ACETONIDE
Generic name: TRIAMCINOLONE ACETONIDE
Manufacturer: QUAGEN PHARMACEUTICALS LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 22c80caa-730e-41c4-b772-18a369e76885
SPL ID: 169c7648-6f18-42cc-a6a9-c96a9bc16e9a
Version: 4
Effective date: 2023-02-15
Source export date: 2026-10-12
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b939c18fdf51df171cf60ce5558819d08ac66bb16bb9991d48cbec91028d783e/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:37:13

Harmonized routes table
Harmonized routes
DENTAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 14 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	214582	derived:openfda.application_number
application number		ANDA214582	openfda.application_number
brand name		TRIAMCINOLONE ACETONIDE	openfda.brand_name
generic name		TRIAMCINOLONE ACETONIDE	openfda.generic_name
manufacturer name		QUAGEN PHARMACEUTICALS LLC	openfda.manufacturer_name
ndc	package	70752-140-16	openfda.package_ndc
ndc	package	70752-140-17	openfda.package_ndc
ndc	product	70752-140	openfda.product_ndc
ndc11	package	70752014016	derived:openfda.package_ndc
ndc11	package	70752014017	derived:openfda.package_ndc
rxcui		1085728	openfda.rxcui
spl id		169c7648-6f18-42cc-a6a9-c96a9bc16e9a	id
spl set id		22c80caa-730e-41c4-b772-18a369e76885	set_id
unii		F446C597KA	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The following local adverse reactions may occur with corticosteroid-containing dental pastes: burning, itching, irritation, dryness, blistering or peeling not present prior to therapy, perioral dermatitis, allergic contact dermatitis, maceration of the oral mucosa, secondary infection, and atrophy of the oral mucosa. Also, see PRECAUTIONS for potential effects of systemic absorption.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.